←
Johannes Kaesmacher472 posts
Johannes Kaesmacher avatar

Johannes Kaesmacher

@CheesemakerMD

INR/Clinician scientist @inselgruppe @ScanNeuroradBE | Neurovascular Research Team | Stroke

◷ Joined November 2019▧ 10 Photos and videos
Fabiano avatar
⟳ Johannes Kaesmacher retweeted
Fabiano@fwcavalcante·Apr 24

For stroke patients that can directly undergo EVT, is IVT before EVT cost effective? Find out more in this great work by Chi Nguyen and the IRIS collaboration. neurology.org/doi/10.1212/WN… @GreenJournal ,@manonkappelhof ,@kiliantreurniet ,@CheesemakerMD ,@FishingNeurons

Adnan Mujanović avatar
⟳ Johannes Kaesmacher retweeted
Adnan Mujanović@adnan_mujanovic·19 Dec 2025

Amazingly executed Michele! It's great to see growing evidence for the DOT ⚪️ Also thanks to @DOWindecker for his hard work on the inital DOT paper @StrokeBern @CheesemakerMD @TDobrocky @Eikeip @TotoMynell @DavidSeiffge @FishingNeurons

9/ 🇮🇹 Final note Kudos to Valentina Tudisco, Prof. Toscano stroke team @unimessina , and the @AUSLRomagna neuro & NRI team! 💡and kudos to @adnan_mujanovic @CheesemakerMD @FishingNeurons and @StrokeBern team for describing DOT first! Read the full study jnnp.bmj.com/content/early/2…

DO-IT Trial avatar
⟳ Johannes Kaesmacher retweeted
DO-IT Trial@DOIT_trial·10 Dec 2025

🚀Breaking news🚀We would like to welcome the @DOIT_trial study teams in Ulm, Leipzig, Ludwigshafen, and Bad Neustadt to the @DOIT_trial community!🥳 we are thrilled to have you on board, actively screening and recruiting patients!

Post attachmentPost attachmentPost attachmentPost attachment
NEJM avatar
⟳ Johannes Kaesmacher retweeted
NEJM@NEJM·21 Nov 2025

Presented at #SVIN25: CREST-2: In high-grade asymptomatic carotid stenosis, addition of stenting to medical therapy led to a lower risk of stroke over a 4-year period. Endarterectomy did not lead to a significant benefit. Full results: nej.md/3LK9kst Editorial: Managing Asymptomatic Carotid Stenosis nej.md/482XjG1 @svinsociety

Post attachment
Fabiano avatar
⟳ Johannes Kaesmacher retweeted
Fabiano@fwcavalcante·29 Oct 2025

Excelente oportunidade e grande iniciativa!! 👏👏👏 @sheilambrasil @FishingNeurons

📣 Calling all stroke specialists in Latin America! Join us in São Paulo, Dec 2–5 2025, for the first Latin America Stroke Summer School from University of Bern in partnership with Rede Brasil AVC and ESO, endorsed by WSO. 🎥 Check out Urs Fischer’s invitation and get ready for this groundbreaking event! 🔗 strokersummeravc.com.br | #AVC #Stroke @RedeBrasilAVC

0:35
McMaster Stroke Program avatar
⟳ Johannes Kaesmacher retweeted
McMaster Stroke Program@McmasterStroke·26 Oct 2025

The DO-IT study is gaining momentum in Europe, and Canada is next! 🇨🇦 Are you ready to DO IT? 👍💪💉

🔊 Exciting DO-IT Trial Update!🔊 📈 🌍 The trial continues to expand, with 24 sites actively recruiting across Europe and 33 patients enrolled so far! - 27 in🇨🇭 - 3 in the 🇳🇱 - 2 in 🇧🇪 - 1 in 🇪🇸 👏 A big thank you to everyone contributing! 💉🧑‍⚕️Recruit. Care. Cure. DO-IT!

Post attachment
Thomas Meinel avatar
⟳ Johannes Kaesmacher retweeted
Thomas Meinel@TotoMynell·25 Oct 2025

In patients with chronic coronary syndrome taking oral anticoagulants, adding aspirin led to higher risks of cardiovascular events, major bleeding, and death from any cause than anticoagulation alone. DO NOT ADD ASS TO (D)OAC for chronic CAD nejm.org/do/10.1056/NEJMdo00…

NEJM@NEJM24 Oct 2025

Original Article: Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation (AQUATIC trial) nej.md/45AU4Wp #Cardiology

Post attachment
DO-IT Trial avatar
⟳ Johannes Kaesmacher retweeted
DO-IT Trial@DOIT_trial·24 Oct 2025

🔊 Exciting DO-IT Trial Update!🔊 📈 🌍 The trial continues to expand, with 24 sites actively recruiting across Europe and 33 patients enrolled so far! - 27 in🇨🇭 - 3 in the 🇳🇱 - 2 in 🇧🇪 - 1 in 🇪🇸 👏 A big thank you to everyone contributing! 💉🧑‍⚕️Recruit. Care. Cure. DO-IT!

Post attachment